RZLT
RZLT
NASDAQ · Biotechnology

Rezolute Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$3.21
+0.12 (+3.88%)
As of May 9, 1:56 AM ET ·
Analyst Consensus
Buy
16
Analysts
High
Coverage
Buy 11 69%
Hold 5 31%
Sell 0 0%
Price Target
Analyst Price Target +440.5% upside
Low Target $11.58
Average Target $17.35
High Target $20.59
Current Price $3.21
Current
$3.21
Target
$17.35
$11.58 $17.35 avg $20.59
Scenario Analysis
Bear Case
$11.58
260.7%
Low target
Base Case
$17.35
+440.5%
Avg target
Bull Case
$20.59
+541.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$11.46
-72.0% from high
52-Week Low
$1.07
+200.0% from low
Target vs 52W High
$17.35
+51.4% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.18
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%